Conjugate Addition to Polyconjugated Nitroolefins
FULL PAPER
113.9, 86.1, 83.3, 79.9, 55.3, 26.1, 18.3 ppm; HRMS (EI): m/z calcd for
C12H13NO3: 219.0895 [M]+; found: 219.0898; [a]D25 = +20.2 (c=1, CHCl3)
for 83% ee. The enantiomeric excess was determined by SFC on a chiral
stationary phase (Chiralcel OD column, method: MeOH 0%-2–1–15,
58C): tR1 =5.59, tR2 =5.99 min.
by column chromatography (cyclohexane/ethyl acetate, 98:2) to afford
2m (68%) as a pale-yellow oil. H NMR (400 MHz, CDCl3): d=7.40 (m,
1
2H), 7.30 (m, 3H), 4.54 (dd, J=12.1, 7.6 Hz, 1H), 4.46 (dd, J=12.4,
7.1 Hz, 1H), 3.48 (m, 1H), 1.49–1.68 (m, 4H), 0.99 ppm (t, J=7.6 Hz,
3H); 13C NMR (100 MHz, CDCl3): d=131.8, 128.4, 128.3, 122.7, 86.6,
84.4, 78.8, 34.12, 31.3, 20.2, 13.7 ppm; HRMS (EI): m/z calcd for
C13H15NO2: 217.1103 [M]+; found: 217.1105; [a]D25 =À7.7 (c=1, CHCl3)
for 60% ee. The enantiomeric excess was determined by SFC on a chiral
stationary phase (Chiralcel OD column, method: MeOH 0%-2–1–15,
58C): tR1 =9.63, tR2 =10.21 min.
1-Bromo-4-(3-methyl-4-nitrobut-1-ynyl)benzene (2h): The reaction was
performed according to general procedure 1. The crude product was puri-
fied by column chromatography (cyclohexane/ethyl acetate, 98:2) to
afford 2h (64%) as a pale-yellow crystal. 1H NMR (400 MHz, CDCl3):
d=7.42 (d, J=8.6 Hz, 2H), 7.24 (d, J=8.6 Hz, 2H), 4.53 (dd, J=12.4,
7.6 Hz, 1H), 4.41 (dd, J=12.1, 7.3 Hz, 1H), 3.54 (m, 1H), 1.37 ppm (d,
J=6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=133.1, 131.5, 122.6,
121.4, 88.7, 82.4, 79.5, 26.0, 18.0 ppm; HRMS (EI): m/z calcd for
C11H10BrNO2: 266.9895 [M]+; found: 266.9893; [a]2D5 = +20.8 (c=1,
CHCl3) for 95% ee. The enantiomeric excess was determined by GC on
a chiral stationary phase (HYDRODEX B-6-TBDM column, method:
60–0–1–170–5, 45 cmsÀ1): tR1 =137.76, tR2 =138.43 min.
[5-Methyl-3-(nitromethyl)hex-1-yn-1-yl]benzene (2n): The reaction was
performed according to general procedure 1. The crude product was puri-
fied by column chromatography (cyclohexane/ethyl acetate, 98:2) to
afford 2n (55%) as a pale-yellow oil. 1H NMR (400 MHz, CDCl3): d=
7.40 (m, 2H), 7.30 (m, 3H), 4.54 (dd, J=12.1, 7.8 Hz, 1H), 4.44 (dd, J=
12.1, 6.8 Hz, 1H), 3.51 (m, 1H), 1.96 (m, 1H), 1.59 (m, 1H), 1.32 (m,
1H), 0.99 ppm (t, J=7.6 Hz, 6H); 13C NMR (100 MHz, CDCl3): d=
131.8, 128.4, 128.3, 122.7, 86.6, 84.3, 79.1, 41.0, 29.9, 26.0, 23.3, 21.4 ppm;
HRMS (EI): m/z calcd for C14H17NO2: 231.1259 [M]+; found: 231.1262;
[a]2D5 =À2.1 (c=1, CHCl3) for 6% ee. The enantiomeric excess was deter-
mined by SFC on a chiral stationary phase (Chiralcel OD column,
method: MeOH 0%-2–1–15, 58C): tR1 =6.29, tR2 =6.90 min.
1-(3-Methyl-4-nitrobut-1-yn-1-yl)-4-(trifluoromethyl)benzene (2i): The
reaction was performed according to general procedure 1. The crude
product was purified by column chromatography (cyclohexane/ethyl ace-
tate, 98:2) to afford 2i (52%) as a brown oil. 1H NMR (400 MHz,
CDCl3): d=7.55 (d, J=8.3 Hz, 2H), 7.48 (d, J=8.4 Hz, 2H), 4.55 (dd,
J=12.1, 7.3 Hz, 1H), 4.44 (dd, J=12.1, 7.1 Hz, 1H), 3.58 (m, 1H),
1.40 ppm (t, J=7.1 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=132.0,
126.4, 125.3, 125.2, 122.5, 90.1, 82.2, 79.4, 26.0, 18.0 ppm; HRMS (EI): m/
z calcd for C12H10F3NO2: 257.0664 [M]+; found: 257.0667; [a]D25 = +16.2
(c=1, CHCl3) for 90% ee. The enantiomeric excess was determined by
GC on a chiral stationary phase (LIPODEX E column, method: 60–0–1–
170–5, 45 cmsÀ1): tR1 =70.90, tR2 =71.39 min.
1-[(E)-3-Methyl-4-nitrobut-1-enyl]benzene (4a): The reaction was per-
formed according to general procedure 1. The crude product was purified
by column chromatography (cyclohexane/ethyl acetate, 98:2) to afford 4a
(70%) as yellow crystals. 1H NMR (400 MHz, CDCl3): d=7.36–7.30 (m,
4H), 7.27–7.23 (m, 1H), 6.50 (d, J=16 Hz, 1H), 6.05 (dd, J=15.9,
7.8 Hz, 1H), 4.38 (m, 2H), 3.22 (m, 1H), 1.23 ppm (d, J=6.8 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=136.4, 131.8, 128.8, 128.6, 127.8, 126.3,
80.9, 36.4, 17.5 ppm; HRMS (EI): m/z calcd for C11H13NO2: 191.0946
[M]+; found: 191.0949; [a]2D5 = +79.7 (c=1, CHCl3) for 88% ee. The
enantiomeric excess was determined by GC on a chiral stationary phase
(LIPODEX E column, method: 60–0–1–170–5, 45 cmsÀ1): tR1 =73.07,
1-Isopropyl-2-(3-methyl-4-nitrobut-1-ynyl)benzene (2j): The reaction was
performed according to general procedure 1. The crude product was puri-
fied by column chromatography (cyclohexane/ethyl acetate, 98:2) to
1
afford 2j (62%) as a brown oil. H NMR (400 MHz, CDCl3): d=7.36 (d,
t
R2 =73.51 min.
J=7.8 Hz, 1H), 7.23–7.30 (m, 2H), 7.11 (m, 1H), 4.56 (dd, J=12.1,
7.3 Hz, 1H), 4.44 (dd, J=12.1, 7.32 Hz, 1H), 3.60 (m, 1H), 3.35 (m, 1H),
1.41 (d, J=6.8 Hz, 3H), 1.25 ppm (d, J=7.1 Hz, 6H); 13C NMR
(100 MHz, CDCl3): d=150.6, 132.5, 128.8, 125.5, 124.9, 121.3, 91.1, 82.2,
79.8, 31.5, 26.3, 23.0, 18.3 ppm; HRMS (EI): m/z calcd for C14H17NO2:
231.1259 [M]+; found: 231.1258; [a]D25 = +15.3 (c=1, CHCl3) for 88% ee.
The enantiomeric excess was determined by GC on a chiral stationary
phase (HYDRODEX B-6-TBDM column, method: 60–0–1–170–5,
45 cmsÀ1): tR1 =106.90, tR2 =107.35 min.
1-Methoxy-4-[(E)-3-methyl-4-nitrobut-1-enyl]benzene (4b): The reaction
was performed according to general procedure 1. The crude product was
purified by column chromatography (cyclohexane/ethyl acetate, 98:2) to
afford 4b (50%) as a yellow solid. 1H NMR (400 MHz, CDCl3): d=7.28
(d, J=8.8 Hz, 2H), 6.85 (d, J=8.8 Hz, 2H), 6.44 (d, J=15.9 Hz, 1H),
5.90 (dd, J=15.6, 7.8 Hz, 1H), 4.36 (m, 2H), 3.80 (s, 3H), 3.19 (m, 1H),
1.21 ppm (d, J=6.8 Hz, 3H); 13C NMR (100 MHz, CDCl3): d=159.3,
131.2, 129.2, 127.5, 126.6, 113.9, 81.1, 55.3, 36.5, 17.6 ppm. HRMS (EI):
m/z calcd for C12H15NO3: 221.1052 [M]+; found: 221.1054; [a]D25 = +70.5
(c=1, CHCl3) for 77% ee. The enantiomeric excess was determined by
SFC on a chiral stationary phase (Chiralcel OB column, method: MeOH
0%-2–1–15, 58C): tR1 =8.77, tR2 =9.48 min.
[3-(Nitromethyl)pent-1-yn-1-yl] (2k): The reaction was performed ac-
cording to general procedure 1. The crude product was purified by
column chromatography (cyclohexane/ethyl acetate, 98:2) to afford 2k
(53%) as an orange oil. 1H NMR (400 MHz, CDCl3): d=7.40 (m, 2H),
7.30 (m, 3H), 4.55 (dd, J=12.1, 7.5 Hz, 1H), 4.47 (dd, J=12.4, 7.3 Hz,
1H), 3.41 (m, 1H), 1.58–1.74 (m, 2H), 1.14 ppm (t, J=7.3 Hz, 3H);
13C NMR (100 MHz, CDCl3): d=131.8, 128.4, 128.3, 122.7, 86.4, 84.5,
78.4, 33.0, 25.4, 11.3 ppm; HRMS (EI): m/z calcd for C12H13NO2:
203.0946 [M]+; found: 203.0948; [a]D25 =À4.5 (c=1, CHCl3) for 62% ee.
The enantiomeric excess was determined by SFC on a chiral stationary
(E)-Ethyl 2-methyl-5-nitropent-3-enoate (4c): The reaction was per-
formed according to general procedure 1. The crude product was purified
by column chromatography (cyclohexane/ethyl acetate, 98:2) to afford 4c
(55%) as an orange oil. 1H NMR (400 MHz, CDCl3): d=7.06 (d, J=
8.6 Hz, 2H), 6.78 (d, J=8.4 Hz, 2H), 5.93 (d, J=15.8 Hz, 1H), 5.90 (dd,
J=15.9, 7.8 Hz, 1H), 3.53 (m, 2H), 2.65 (m, 1H), 0.62 ppm (d, J=15.8,
6.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): d=134.9, 133.4, 130.7, 129.5,
128.7, 127.5, 80.8, 36.4, 17.5 ppm; HRMS (EI): m/z calcd for
C11H12ClNO2: 225.0557 [M]+; found: 225.0557; [a]2D5 = +63.0 (c=1,
CHCl3) for 84% ee. The enantiomeric excess was determined by SFC on
a chiral stationary phase (Chiralcel OB column, method: MeOH 0%-2–
1–15, 58C): tR1 =7.17, tR2 =7.63 min.
phase (Chiralcel OD column, method: MeOH 0%-2–1–15, 58C): tR1
4.41, tR2 =4.85 min.
=
[3-(Nitromethyl)hept-1-yn-1-yl]benzene (2l): The reaction was per-
formed according to general procedure 1. The crude product was purified
by column chromatography (cyclohexane/ethyl acetate, 98:2) to afford 2l
(65%) as a red oil. 1H NMR (400 MHz, CDCl3): d=7.40 (m, 2H), 7.30
(m, 3H), 4.54 (dd, J=12.1, 7.8 Hz, 1H), 4.46 (dd, J=12.1, 7.1 Hz, 1H),
3.46 (m, 1H), 0.92–1.63 (m, 6H), 0.94 ppm (t, J=7.3 Hz, 3H); 13C NMR
(100 MHz, CDCl3): d=131.8, 128.4, 128.3, 122.7, 86.7, 84.4, 78.8, 31.8,
31.5, 29.0, 22.3, 14.0 ppm; HRMS (EI): m/z calcd for C14H17NO2:
231.1259; found: 231.1261; [a]2D5 =À13.7 (c=1, CHCl3) for 71% ee. The
enantiomeric excess was determined by SFC on a chiral stationary phase
(Chiralcel OD column, method: MeOH 0%-2–1–15, 58C): tR1 =4.70,
(E)-(3-Methyl-4-nitrobut-1-en-1-yl)cyclohexane (4d): The reaction was
performed according to general procedure 1. The crude product was puri-
fied by column chromatography (cyclohexane/ethyl acetate, 98:2) to
afford 4d (59%) as a yellow oil. 1H NMR (400 MHz, CDCl3): d=5.49
(dd, J=15.4, 6.6 Hz, 1H), 5.21 (dd, J=15.4, 6.6 Hz, 1H), 4.25 (m, 2H),
2.95 (m, 1H), 1.88 (m, 1H), 1.62–1.72 (m, 6H), 1.03–1.29 ppm (m, 7H);
13C NMR (100 MHz, CDCl3): d=139.1, 126.7, 81.5, 40.5, 36.3, 32.9, 26.1,
26.0, 17.8 ppm; HRMS (EI): m/z calcd for C11H18: 150.1409 [MÀHNO2]+;
found: 150.1407; [a]2D5 = +27.6 (c=1, CHCl3) for 90% ee. The enantio-
meric excess was determined by GC on a chiral stationary phase (LIPO-
tR2 =5.30 min.
[3-(Nitromethyl)hex-1-yn-1-yl]benzene (2m): The reaction was per-
formed according to general procedure 1. The crude product was purified
Chem. Eur. J. 2013, 19, 11352 – 11363
ꢃ 2013 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
11361